Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer

Administer via intraperitoneal infusion for 3 or 6 doses Q3D.

"Physician's Choice of carboplatin (preferred) or cisplatin，gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin，with or without bevacizumab.~Administer beginning in Week 5 or Week 6."